skip navigation

Skip Nav

Clinical Guidelines Portal

Clinical Guidelines Portal

Guidelines for the Prevention and Treatment of Opportunistic Infections in HIV-Infected Adults and Adolescents

Appendix C: Panel Roster and Financial Disclosures


(Last updated: November 1, 2012; last reviewed: November 1, 2012)

Hepatitis B Virus
Member Financial Disclosure
Company Relationship
Bhattacharya, Debika
University of California, Los Angeles Vertex Research Support
Hu, Dale Centers for Disease Control and Prevention
Biotest Travel Support
Orasure Stock Holder
Pfizer Stock Holder
Nunez, Marina
Wake Forest University Health Sciences
Bristol-Myers Squibb
Research Support
Peters, Marion*

University of California, San Francisco

Biotron Consultant
Clinical Care Options
Advisory Board
Genetech Other
GReD Spouse has relationship
International Antiviral Society (IAS-USA)
Advisory Board, Speaker’s Bureau
Merck Advisory Board, Honoraria
Roche Consultant, Honoraria
Theravance Advisory Board
Vertex Honoraria
Thio, Chole Johns Hopkins University
None N/A
*Group lead

Note: Members were asked to disclose all relationships from 24 months before the writing panel convened. The period of reporting was from June 1, 2008, through November 1, 2012.

Back to Top